Townsend Adam J.
Insider CIK 1773588 · APLS See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APLS Apellis Pharmaceuticals, I | S Sale | 2025-01-29 | 2025-01-30 | 695 | $29.52 | $20.5K | 84,050 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2025-01-22 | 2025-01-23 | 3,323 | $30.43 | $101.1K | 84,745 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2025-01-17 | 2025-01-21 | 2,201 | $29.96 | $65.9K | 88,068 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2025-01-13 | 2025-01-14 | 2,685 | $28.70 | $77.1K | 90,269 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2024-02-12 | 2024-02-13 | 1,148 | $67.77 | $77.8K | 92,453 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2024-01-29 | 2024-01-31 | 906 | $64.14 | $58.1K | 93,601 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2024-01-22 | 2024-01-23 | 3,413 | $65.00 | $221.8K | 94,507 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2024-01-16 | 2024-01-17 | 34,533 | $66.30 | $2.29M | 34,533 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2024-01-16 | 2024-01-17 | 23,748 | — | $0 | 100,155 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2024-01-16 | 2024-01-17 | 2,235 | $66.81 | $149.3K | 97,920 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2023-12-01 | 2023-12-05 | 110,000 | — | $0 | 172,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2023-12-01 | 2023-12-05 | 110,000 | $15.09 | $1.66M | 186,407 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2023-12-01 | 2023-12-05 | 67,557 | $60.50 | $4.09M | 118,850 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2023-12-01 | 2023-12-05 | 42,443 | $61.31 | $2.60M | 76,407 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2023-05-03 | 2023-05-04 | 5,000 | — | $0 | 282,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2023-05-03 | 2023-05-04 | 5,000 | $82.71 | $413.5K | 75,995 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2023-05-03 | 2023-05-04 | 5,000 | $15.09 | $75.5K | 80,995 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2023-04-03 | 2023-04-05 | 5,000 | — | $0 | 287,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2023-04-03 | 2023-04-05 | 5,000 | $15.09 | $75.5K | 80,995 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2023-04-03 | 2023-04-05 | 5,000 | $74.05 | $370.3K | 75,995 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2023-03-03 | 2023-03-07 | 5,000 | — | $0 | 292,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2023-03-03 | 2023-03-07 | 5,000 | $63.84 | $319.2K | 75,995 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2023-03-03 | 2023-03-07 | 5,000 | $15.09 | $75.5K | 80,995 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2023-02-21 | 2023-02-22 | 14,023 | — | $0 | 14,023 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2023-02-21 | 2023-02-22 | 9,886 | — | $0 | 77,036 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2023-02-21 | 2023-02-22 | 1,041 | $58.50 | $60.9K | 75,995 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2023-02-10 | 2023-02-14 | 782 | $51.21 | $40.0K | 67,150 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2023-02-03 | 2023-02-06 | 5,000 | — | $0 | 297,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2023-02-03 | 2023-02-06 | 5,000 | $15.09 | $75.5K | 72,932 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2023-02-03 | 2023-02-06 | 5,000 | $55.85 | $279.3K | 67,932 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2023-01-27 | 2023-01-30 | 551 | $52.77 | $29.1K | 67,932 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2023-01-20 | 2023-01-24 | 1,912 | $52.05 | $99.5K | 68,483 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2023-01-12 | 2023-01-17 | 43,183 | $52.66 | $2.27M | 43,183 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2023-01-12 | 2023-01-17 | 27,488 | — | $0 | 70,395 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2023-01-03 | 2023-01-05 | 5,000 | — | $0 | 302,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2023-01-03 | 2023-01-05 | 5,000 | $50.70 | $253.5K | 42,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2023-01-03 | 2023-01-05 | 5,000 | $15.09 | $75.5K | 47,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-12-05 | 2022-12-07 | 5,000 | — | $0 | 307,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-12-05 | 2022-12-07 | 5,000 | $50.38 | $251.9K | 42,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-12-05 | 2022-12-07 | 5,000 | $15.09 | $75.5K | 47,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-11-03 | 2022-11-07 | 5,000 | — | $0 | 312,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-11-03 | 2022-11-07 | 5,000 | $15.09 | $75.5K | 47,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-11-03 | 2022-11-07 | 5,000 | $58.54 | $292.7K | 42,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-10-03 | 2022-10-05 | 5,000 | — | $0 | 317,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-10-03 | 2022-10-05 | 5,000 | $66.69 | $333.4K | 42,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-10-03 | 2022-10-05 | 5,000 | $15.09 | $75.5K | 47,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-09-06 | 2022-09-07 | 5,000 | — | $0 | 322,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-09-06 | 2022-09-07 | 5,000 | $60.38 | $301.9K | 42,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-09-06 | 2022-09-07 | 5,000 | $15.09 | $75.5K | 47,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-08-15 | 2022-08-16 | 12,500 | — | $0 | 327,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-08-15 | 2022-08-16 | 12,500 | $69.00 | $862.5K | 42,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-08-15 | 2022-08-16 | 12,500 | $15.09 | $188.6K | 55,407 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-08-11 | 2022-08-12 | 12,500 | — | $0 | 340,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-08-11 | 2022-08-12 | 12,500 | $67.00 | $837.5K | 42,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-08-11 | 2022-08-12 | 12,500 | $15.09 | $188.6K | 55,407 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-08-08 | 2022-08-09 | 12,500 | — | $0 | 352,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-08-08 | 2022-08-09 | 12,500 | $65.00 | $812.5K | 42,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-08-08 | 2022-08-09 | 12,500 | $15.09 | $188.6K | 55,407 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-08-03 | 2022-08-04 | 5,000 | — | $0 | 365,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-08-03 | 2022-08-04 | 5,000 | $56.43 | $282.1K | 37,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-08-03 | 2022-08-04 | 5,000 | $15.09 | $75.5K | 42,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-07-11 | 2022-07-12 | 5,000 | — | $0 | 370,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-07-11 | 2022-07-12 | 5,000 | $48.42 | $242.1K | 42,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-07-11 | 2022-07-12 | 5,000 | $15.09 | $75.5K | 47,907 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | J Other deriv | 2022-04-21 | 2022-07-12 | 11,250 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | J Other | 2022-04-21 | 2022-07-12 | 1,875 | — | $0 | 42,138 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2022-02-10 | 2022-02-14 | 895 | $47.12 | $42.2K | 44,013 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2022-01-28 | 2022-02-01 | 800 | $38.59 | $30.9K | 44,908 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2022-01-21 | 2022-01-25 | 36,951 | — | $0 | 36,951 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2022-01-21 | 2022-01-25 | 26,051 | — | $0 | 45,708 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2021-02-10 | 2021-02-11 | 688 | $47.72 | $32.8K | 18,865 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2021-01-28 | 2021-02-01 | 45,000 | — | $0 | 45,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2021-01-28 | 2021-02-01 | 11,250 | — | $0 | 11,250 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2021-01-28 | 2021-02-01 | 1,875 | — | $0 | 19,553 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2021-01-28 | 2021-02-01 | 7,500 | — | $0 | 17,678 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2020-02-10 | 2020-02-12 | 56,250 | — | $0 | 56,250 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2020-02-10 | 2020-02-12 | 9,375 | — | $0 | 9,375 | SEC↗ |